For decades, LICORbio’s line of Odyssey® near-infrared (NIR) imaging systems has been the gold standard for sensitivity, reliability, and innovation in biological research. The company’s Odyssey imagers have garnered over 40,000 citations in peer-reviewed articles, as they enable scientists to investigate complex biological processes, elucidate disease mechanisms, and advance scientific discovery—accelerating cancer and genomics research, drug discovery, and cell biology, to name a few relevant fields.
Its latest imaging system, the Odyssey F, builds upon this legacy by providing researchers with greater flexibility, unprecedented speed, and unmatched dynamic range—all in a single acquisition.
Available with either 3 or 10 channels to fit any lab’s unique needs, both Odyssey F models complete scans twice as fast as their LICORbio predecessor and significantly faster than competitive laser-based instruments. Rapid image acquisition (often less than 10 minutes per scan), laser-based multiplexing, and a wider array of supported assays will streamline researchers’ workflows, significantly boost their throughput, and further expand their lab’s horizons.
To put it simply, every scan on an Odyssey F is fast, sensitive, and backed by decades of industry-leading expertise in NIR fluorescence imaging.
The Odyssey F was also designed with sensitivity and versatility in mind. The addition of two visible fluorescence lasers maximizes quantitative results to reveal more actionable insights. Over 6 logs of dynamic range are visible in a single acquisition, and resolutions of 21, 42, 64, 169, and 337 μm are available. Several targets can be multiplexed at once, and an enhanced focus offset range means the Odyssey F is compatible with a wider variety of plates than previous iterations.
Odyssey F imagers are also suitable for a wider range of supported applications than their predecessor. These include EMSA/gel shift assays, glycoprotein staining, nucleic acid gel imaging, fluorescent gel staining, near-infrared fluorescent Western blots, visible fluorescent Western blots, In-cell Western™ assays, on-cell Western assays, RNAi analyses, fluorescent protein assays, tissue section imaging, protein arrays, other plate-based assays, and much more.
Finally, both Odyssey F imaging systems include the same user-friendly features, reliability, reproducibility, and data fidelity that are synonymous with LICORbio’s reputation. And because LICORbio is committed to improving the human condition by supporting scientists every step along the way, the Odyssey F is an exceptional value for the industry-leading capabilities it delivers.